
Vanguard's India holdings rose 44% to Rs 95,903 crore in Q4 CY26, driven by 12 stocks surging 10-87% and two new additions. Track the June quarter filing for confirmation.
Vanguard Funds' India holdings climbed to Rs 95,903 crore across 47 BSE-listed companies as of the March 2026 quarter. That is a 44% increase from Rs 66,403 crore in December 2025, per shareholding data from ACE Equity and Trendlyne. The jump came from both price appreciation and new capital deployment. Two stocks were added to the portfolio during the quarter, confirming fresh allocation rather than passive rebalancing.
Vanguard ranks among the top three active foreign institutional investors in India. A 44% quarter-over-quarter expansion of its India book signals deliberate conviction allocation at a time when global emerging-market flows face headwinds from US rate uncertainty and dollar strength. The portfolio size itself now rivals that of a mid-cap index fund – any 5% shift represents billions of rupees of buying or selling.
The best performer in the portfolio surged 87% so far in CY26, rising from Rs 701 to Rs 1,313. Vanguard held a 2.1% stake valued at approximately Rs 423 crore. That single stock contributed significant notional gain to the quarter-over-quarter increase.
The second stock advanced 76% from Rs 1,677 to Rs 2,946. Vanguard's 1.02% stake was worth roughly Rs 187 crore. Both names outperformed the broader Indian indices by a wide margin, suggesting stock-specific catalysts rather than general market beta.
The remaining ten stocks delivered CYTD returns of:
Only 12 of 47 holdings generated the bulk of the portfolio gain. The remaining 35 contributed less or detracted. That concentration is typical of active stock selection.
Adding two new names during the March 2026 quarter is significant. Vanguard did not simply ride existing positions higher. The fund deployed fresh capital into stocks that were not in the portfolio at December 2025. The identities are not disclosed in the source, the timing during a quarter when the Indian market was rising suggests Vanguard saw relative value or a near-term catalyst in those names.
When a top active FII adds new stocks, it often triggers attention from domestic and global institutional investors. The two newcomers could see follow-on buying if they appear in the next quarterly filings. However – the effect depends on liquidity and market cap. Small-cap additions are harder to replicate.
Vanguard's India book at Rs 95,903 crore is large enough to move individual stock prices during daily liquidity windows. The 44% increase implies net inflows from Vanguard's global funds into Indian equities, contributing to overall FII flows during the quarter. For reference, total FII net purchases on the NSE in the March quarter were roughly Rs 1.2 lakh crore. Vanguard's growth accounted for about a quarter of that total.
Vanguard's holdings are tracked by brokerages and quantitative funds. A 44% surge with two new additions can trigger rebalancing by peers who benchmark against Vanguard's portfolio. The read-through is not mechanical because many funds have different mandates, it reinforces the narrative that India is a preferred EM weight.
The top stock is up 87% in CY26. That kind of move creates valuation risk. Vanguard's average entry price for that stock was likely lower than the current Rs 1,313. The fund is sitting on large unrealized gains. For new buyers, the risk/reward has narrowed significantly. The same applies to the stock up 76% and several others in the 20-30% range.
To sustain the rally, earnings growth must catch up to price. If the top stock's next quarterly earnings beat consensus, Vanguard's conviction is validated. If fundamentals disappoint, the 87% gain could unwind. A checklist for each of the 12 high-return names:
The two new entrants carry higher uncertainty because their holding periods are shorter. Vanguard may cut them faster than older positions if they underperform.
Although the source does not name individual stocks, Vanguard's portfolio of 47 BSE-listed companies likely spans financials (banks, NBFCs), technology, consumer goods, and pharma – the typical large-cap mix. The largest single stake in the detail above is Rs 1,576.4 crore in a bank, confirming significant weight in financials. The inclusion of two new names in Q4 may point to a sector Vanguard is overweighting. Past patterns suggest increased exposure to domestic cyclicals and healthcare.
Without the names, traders should watch for sector-level shifts in the June quarter filings of other large FIIs. If Vanguard added exposure to manufacturing or renewable energy, that would signal a thematic pivot. If the new names are in technology, it would imply a value rotation rather than a growth bet.
The next data point will be the June 2026 quarter shareholding pattern, due for publication by August 14, 2026. By then, the performance of the 12 existing stocks and the fate of the two new entrants will be clearer. Key questions:
For ongoing tracking of Vanguard's moves and broader India flows, refer to AlphaScala's stock market analysis.
A 44% portfolio jump is a strong institutional conviction signal. Without stock names, the actionable opportunity lies in the two new additions – once identified, rigorous fundamentals work will separate alpha from momentum.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.